Early research (Phase 1)Study completedNCT02308722What this trial is testingSBRT Pre-operatively for Pancreatic CancerWho this might be right forPancreatic Neoplasms University of Oxford 12
Testing effectiveness (Phase 2)Looking for participantsNCT06538857What this trial is testingCEB-01 in Locally Resectable Pancreatic CancerWho this might be right forPancreatic Carcinoma CEBIOTEX 39
Not applicableLooking for participantsNCT06320717What this trial is testingAI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal AdenocarcinomaWho this might be right forPancreatic Ductal Adenocarcinoma Roswell Park Cancer Institute 100
Not applicableLooking for participantsNCT06595160What this trial is testingDetermining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant ChemotherapyWho this might be right forBorderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaStage I Pancreatic Cancer AJCC v8 Emory University 87
Very early researchStudy completedNCT01992705What this trial is testingBorderline Pancreas Study: FOLFIRINOX +SBRTWho this might be right forResectable Pancreatic Cancer University of Maryland, Baltimore 8
Not applicableUnknownNCT05489458What this trial is testingPredictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant TherapyWho this might be right forCarcinoma, Pancreatic Ductal BUSQUETS, JULI 100
Testing effectiveness (Phase 2)Ended earlyNCT01760252What this trial is testingNeoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma ProtocolWho this might be right forMetastatic Pancreatic Adenocarcinoma Beth Israel Medical Center 17
Testing effectiveness (Phase 2)UnknownNCT01591733What this trial is testingFOLFIRINOX + RT for Pancreatic CancerWho this might be right forPancreatic Cancer Massachusetts General Hospital 48
Testing effectiveness (Phase 2)Study completedNCT02243358What this trial is testingPhase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic CancerWho this might be right forPancreas Neoplasm Malignant Resectable Henry Ford Health System 24
Testing effectiveness (Phase 2)Study completedNCT01560949What this trial is testingPreoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the PancreasWho this might be right forPancreatic Cancer M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT02749136What this trial is testingNeoadjuvant Modified FOLFIRINOX in Borderline Resectable Pancreatic CancerWho this might be right forPancreatic Adenocarcinoma Asan Medical Center 44
Testing effectiveness (Phase 2)WithdrawnNCT04130399What this trial is testingStudy of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic CancerWho this might be right forPancreatic CancerPancreatic Adenocarcinoma Indiana University
Not applicableStudy completedNCT05888129What this trial is testingClinical Outcomes of Surgery After Neoadjuvant Chemotherapy in Locally Advanced Pancreatic CancerWho this might be right forPostoperative Complications Asan Medical Center 1
Not applicableLooking for participantsNCT06944587What this trial is testingA New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic CancerWho this might be right forLocally Advanced Pancreatic CancerBorderline Resectable Pancreatic CancerPancreatectomy+1 more Oslo University Hospital 400
Testing effectiveness (Phase 2)Study completedNCT04548440What this trial is testingEfficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC PatientsWho this might be right forEsophageal Squamous Cell Carcinoma Sun Yat-sen University 50
Testing effectiveness (Phase 2)Ended earlyNCT04327986What this trial is testingImmune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas CancerWho this might be right forHistologically or Cytologically Confirmed Pancreatic CancerUnresectable or Borderline Resectable Pancreatic CancerPancreatic Neoplasms+2 more National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07277452What this trial is testingNimotuzumab Combined With Nab-paclitaxel/Gemcitabine in the Perioperative Treatment of High-risk Resectable/Borderline Resectable Pancreatic CancerWho this might be right forPancreatic Cancer, Adult The First Affiliated Hospital with Nanjing Medical University 156
Testing effectiveness (Phase 2)Looking for participantsNCT06821997What this trial is testingNALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar TrialWho this might be right forBorderline Resectable Pancreatic Ductal Adenocarcinoma Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)UnknownNCT01676259What this trial is testingSiG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic CancerWho this might be right forPancreatic Ductal AdenocarcinomaPancreatic Cancer Silenseed Ltd 80
Not applicableStudy completedNCT02318095What this trial is testingGemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic CancerWho this might be right forResectable Pancreatic Cancers Duke University 40